Pharmaceutic agent, method of treating psychoses, method of obtaining ziprasidone hydrochloride monohydrate and method of obtaining such pharmaceutic agent

摘要

Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 mu m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.